Viewing nowKosal Tablet (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 200500474 · Notified 2005.02.01 · Insurance code 693901040
Treatment of kidney disease in patients with hypertension and type 2 diabetes mellitus
This medication is used for the treatment of hypertension, particularly effective in patients with both hypertension and nephropathy due to type 2 diabetes. It helps in the stable management of blood pressure and in preventing the deterioration of kidney function. It is used to reduce the risk of complications associated with hypertension and to improve overall health.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension — The recommended initial and maintenance dose is losartan potassium 50 mg orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is inadequate, the same dose may be divided and administered orally twice daily, or increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension — The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No adjustment of the initial dose is required in older adults aged 75 years or younger. For older adults over 75 years, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is required. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have decreased effective intravascular volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets — The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more — The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age — Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡ — Not recommended. Pediatric patients with hepatic impairment — Not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be used by pregnant women or those who may become pregnant. It is generally unsafe for patients with severe liver or kidney dysfunction, certain genetic disorders, and those with a history of angioedema to use this medication. Elderly patients or those with hyperkalemia, liver impairment, or heart disease should use this drug cautiously, as excessive drops in blood pressure can lead to serious complications. This drug is usually well tolerated, but may occasionally cause a variety of side effects such as dizziness, headache, muscle pain, dyspepsia, cough, and skin rashes, so patients should consult a physician in case of abnormal symptoms. If angioedema or allergic reactions occur, treatment should be discontinued immediately and appropriate care should be sought. Interactions may occur when this drug is used in conjunction with other antihypertensive agents or potassium-sparing diuretics, hence patients should inform their healthcare provider of any other medications they are taking. It is preferable for pregnant or breastfeeding women not to take this drug, and if it is necessary to do so, they should consult a specialist and discontinue nursing. Due to the risk of hypotension, renal failure, hyperkalemia, and other risks, regular monitoring of blood pressure and blood tests to check kidney function and electrolyte status should be performed. This medication can cause sudden drops in blood pressure or loss of consciousness, so particularly at the start of treatment or when changing doses, careful monitoring of the patient's condition is required. It is not recommended for children, especially those under 6 years of age or those with severe renal impairment, as the safety and effectiveness have not been established. In the case of overdose, symptoms such as hypotension and bradycardia may present, necessitating immediate emergency treatment. This drug cannot be removed by hemodialysis, thus caution is necessary. During treatment, patients should not self-administer potassium supplements or potassium-containing salt substitutes, and should consult their healthcare provider if they plan to become pregnant or are currently pregnant. Store in a place out of reach of children, and keep it in its original container to maintain its quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a temperature between 1 to 30 degrees Celsius (room temperature) during storage.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.